Abstract:Background and aims As a member of mitochondrial sirtuins, Sirt4 plays a vital role in cellular metabolism and intracellular signal transduction; however, its effect on atherosclerosis is unclear. This study aimed to explore the effect of Sirt4 on atherosclerosis and its underlying mechanism. Methods In vivo , Apoe −/− and Apoe −/− /Sirt4 −/− mice were fed a high-fat diet to induce atherosclerosis. In vitro , peritoneal macrophages from two mouse types were extracted and treated with oxidized low-density lipoprotein to establish a cell model, THP-1 cells were used to observe the effect of Sirt4 on the adhesion ability of monocytes. The growth and composition of aortic plaques in two mouse types were analyzed by H&E staining, Oil Red O staining, Dil oxidized low-density lipoprotein, immunohistochemistry, real-time quantitative polymerase chain reaction and enzyme-linked immunosorbent assay. Transcriptome analysis and Western blotting were performed to explore the specific mechanism. Results Sirt4 deficiency aggravated atherosclerosis in mice. In vivo , aortic plaque size, lipid content, and expression of related inflammatory factors in Apoe −/− /Sirt4 −/− mice were higher than those in the control group, whereas the contents of collagen I and smooth muscle actin-α were significantly lower. Sirt4-deficient macrophages exhibited stronger lipid phagocytosis in vitro , and the adhesion ability of monocytes increased when Sirt4 expression decreased. Transcriptome analysis showed that the expression of CXCL2 and CXCL3 in Sirt4-deficient peritoneal macrophages increased significantly, which may play a role by activating the NF-κB pathway. In further verification, the results in vitro and in vivo showed that the expression of VCAM-1 and pro-inflammatory factors such as IL-6, TNF-α and IL-1β increased, whereas the expression of anti-inflammatory factor IL-37 decreased in Sirt4-deficient peritoneal macrophages and tissues. After blocking the effect with NK-κB inhibitor BAY11-7082, the inflammatory reaction in sirt4 deficient macrophages was also significantly decreased. Conclusions This study demonstrated that Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway, suggesting that Sirt4 may exhibit a protective effect in atherosclerosis, which provides a new strategy for clinical prevention and treatment of atherosclerosis.

Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells

Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis

SIRT6 Protects Against Endothelial Dysfunction and Atherosclerosis in Mice

SIRT1 inhibition promotes atherosclerosis through impaired autophagy.

Sirtuin 6 Deacetylates Apoptosis-Associated Speck-Like Protein (ASC) to Inhibit Endothelial Cell Pyroptosis in Atherosclerosis

Sirt4 deficiency promotes the development of atherosclerosis by activating the NF-κB/IκB/CXCL2/3 pathway

SIRT6 Inhibits Inflammatory Response Through Regulation of NRF2 in Vascular Endothelial Cells

SIRT6 Promotes Angiogenesis and Hemorrhage of Carotid Plaque Via Regulating HIF-1α and Reactive Oxygen Species

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

SIRT1 mediates the inflammatory response of macrophages and regulates the TIMP3/ADAM17 pathway in atherosclerosis

Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development

SIRT1 prevents atherosclerosis via liver‑X‑receptor and NF‑κB signaling in a U937 cell model.

Sirt6 inhibits vascular endothelial cell pyroptosis by regulation of the Lin28b/let-7 pathway in atherosclerosis

STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis

Sirt6 inhibits vascular endothelial cell pyroptosis by regulation of the Lin28b/let-7 pathway in atherosclerosis.

SIRT6 Inhibits Cholesterol Crystal-Induced Vascular Endothelial Dysfunction Via Nrf2 Activation.

Sirt6 regulates autophagy in AGE-treated endothelial cells via KLF4

Deacetylation of Caveolin-1 by Sirt6 Induces Autophagy and Retards High Glucose-Stimulated LDL Transcytosis and Atherosclerosis Formation

SIRT6 stabilization and cytoplasmic localization in macrophages regulates acute and chronic inflammation in mice

Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health

Role of Argininosuccinate Synthase 1 -Dependent L-Arginine Biosynthesis in the Protective Effect of Endothelial Sirtuin 3 Against Atherosclerosis